Rating Rationale
July 30, 2020 | Mumbai
Gurudeva Charitable Trust
Rating Reaffirmed
 
Rating Action
Total Bank Loan Facilities Rated Rs.27 Crore
Long Term Rating CRISIL B/Stable (Reaffirmed)
1 crore = 10 million
Refer to annexure for Details of Instruments & Bank Facilities
Detailed Rationale

CRISIL has reaffirmed its 'CRISIL B/Stable' rating on the long term bank facilities of Gurudeva Charitable Trust (GCT).
 
The rating continues to reflect GCT's modest scale of operations, geographic concentration in revenue, susceptibility to risks related to regulatory changes, and a weak capital structure. These weaknesses are partially offset by the extensive experience of the trustees in the education industry and their funding support and adequate debt protection metrics.

Analytical Approach

Unsecured loans from the promoters, Rs 20.85 crore as on March 31, 2019, have been treated as neither debt nor equity as the loans are expected to be in the business over the medium term.

Key Rating Drivers & Detailed Description
* Weaknesses:
Modest scale of operations and geographical concentration in revenue:
The entire revenue is derived from a medical college and hospital in Kerala and a single course, resulting in small scale of operations. Revenues were Rs 58.74 crore in fiscal 2019 and are estimated at Rs 61 crore in fiscal 2020. Furthermore, as revenue is derived from just one college, the trust is exposed to geographical concentration risk. Hospital operations have been severly impacted due to shutdown of out-patient department during lockdown and slowdown in non-critical treatments.
 
* Susceptibility to risks related to regulatory changes:
The education sector is highly regulated and compliance with specific operational and infrastructure norms set by regulatory bodies, such as the Medical Council, is essential. Thus, regular investment in the workforce and infrastructure are needed and approvals have to be received even to set up new courses or increase the number of seats for any course.
 
* Weak capital structure: 
Capital structure is leveraged as reflected in high debt and negative networth. Total outside liabilities to tangible networth was high at 2.5 times, estimated as on March 31, 2020. The capital structure is expected to remain at similar levels.
 
Strengths:
* Extensive experience of the trustees and their fund support:
The trustees have extensive experience in the field of education and medical sector. The society has been able to establish a brand name in a short span of time backed by strong focus on quality education in hospital services. Moreover, need-based funding support from the trustees in the form of unsecured loans'Rs 20 crore as on March 31, 2020'is expected to continue.
 
* Adequate debt protection metrics:
Debt protection metrics are expected to remain strong over the medium term. Interest coverage and net cash accrual to adjusted debt ratios were estimated at a healthy 7.86 times and 0.51 time, respectively, in fiscal 2020.
Liquidity Poor

Cash accrual, expected at Rs 6-7 crore each in fiscals 2021 and 2022, should comfortably cover debt obligation of Rs 2.50 crore and Rs 2.90 crore, respectively, and support liquidity. Bank limit of Rs 6 crore was utilised 40% on average for past 12 months ended 31st April 2020. Moratorium has been availed on the bank facilities from March to August 2020.

Outlook: Stable

CRISIL believes GCT will continue to benefit from the extensive experience of its trustees.

Rating Sensitivity factors
Upward factors
* Increase in revenue and profitability leading to better net cash accrual generation.
* Improvement in financial risk profile reflected in better capital structure marked by TOLANW of 1.5 times
 
Downward factors
* Any large capital expenditure weakens the financial risk profile
* Decline in revenue or profitability leading to weak net cash accrual below Rs 4 Crore.
About the Company

GCT, based in Ernakulam, was set up in 2003 by a group of non-resident Indians and businessmen from Kerala. The trust runs a medical college and hospital located at Ernakulam, Sree Narayana Institute of Medical Sciences, offering the MBBS course.

Key Financial Indicators
As on / for the period ended March 31   2019 2018
Operating income Rs crore 58.74 53.07
Reported profit after tax Rs crore 4.17 0.84
PAT margin % 7.09 1.57
Adjusted debt/Adjusted networth Times -3.78 -4.64
Interest coverage Times 7.83 4.32

Any other information: Not applicable

Note on complexity levels of the rated instrument:
CRISIL complexity levels are assigned to various types of financial instruments and are included (where applicable) in the Annexure -- Details of Instrument in this Rating Rationale. For more details on the CRISIL complexity levels, please visit www.crisil.com/complexity-levels.
Annexure - Details of Instrument(s)
ISIN Name of instrument Date of allotment Coupon rate (%) Maturity date Issue size (Rs crore) Complexity Levels Rating assigned with outlook
NA Proposed Long Term Bank Loan Facility NA NA NA 4.5 NA CRISIL B/Stable
NA Term Loan NA NA Mar-2024 10.5 NA CRISIL B/Stable
NA Working Capital Demand Loan NA NA NA 6 NA CRISIL B/Stable
NA Secured Overdraft Facility NA NA NA 6 NA CRISIL B/Stable
Annexure - Rating History for last 3 Years
  Current 2020 (History) 2019  2018  2017  Start of 2017
Instrument Type Outstanding Amount Rating Date Rating Date Rating Date Rating Date Rating Rating
Fund-based Bank Facilities  LT/ST  27.00  CRISIL B/Stable      14-05-19  CRISIL B/Stable  28-05-18  CRISIL B-/Stable  22-02-17  CRISIL B-/Stable  Suspended 
                    31-01-17  CRISIL B-/Stable   
All amounts are in Rs.Cr.
Annexure - Details of various bank facilities
Current facilities Previous facilities
Facility Amount (Rs.Crore) Rating Facility Amount (Rs.Crore) Rating
Proposed Long Term Bank Loan Facility 4.5 CRISIL B/Stable Proposed Long Term Bank Loan Facility 4.5 CRISIL B/Stable
Secured Overdraft Facility 6 CRISIL B/Stable Secured Overdraft Facility 6 CRISIL B/Stable
Term Loan 10.5 CRISIL B/Stable Term Loan 10.5 CRISIL B/Stable
Working Capital Demand Loan 6 CRISIL B/Stable Working Capital Demand Loan 6 CRISIL B/Stable
Total 27 -- Total 27 --
Links to related criteria
CRISILs Approach to Financial Ratios
CRISILs Bank Loan Ratings - process, scale and default recognition
CRISILs criteria for rating Education institutions
CRISILs Approach to Recognising Default
CRISILs Bank Loan Ratings

For further information contact:
Media Relations
Analytical Contacts
Customer Service Helpdesk
Saman Khan
Media Relations
CRISIL Limited
D: +91 22 3342 3895
B: +91 22 3342 3000
saman.khan@crisil.com

Naireen Ahmed
Media Relations
CRISIL Limited
D: +91 22 3342 1818
B: +91 22 3342 3000
naireen.ahmed@crisil.com

Rahul Guha
Director - CRISIL Ratings
CRISIL Limited
D:+91 22 4097 8320
rahul.guha@crisil.com


Ankita Gupta
Associate Director - CRISIL Ratings
CRISIL Limited
D:+91 22 4097 8104
ankita.gupta@crisil.com


Nikhil Kadam
Rating Analyst - CRISIL Ratings
CRISIL Limited
B:+91 22 3342 3000
Nikhil.Kadam@crisil.com
Timings: 10.00 am to 7.00 pm
Toll free Number:1800 267 1301

For a copy of Rationales / Rating Reports:
CRISILratingdesk@crisil.com
 
For Analytical queries:
ratingsinvestordesk@crisil.com


 

Note for Media:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper / magazine / agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL. However, CRISIL alone has the sole right of distribution (whether directly or indirectly) of its rationales for consideration or otherwise through any media including websites, portals etc.


About CRISIL Limited

CRISIL is a leading agile and innovative, global analytics company driven by its mission of making markets function better. We are India’s foremost provider of ratings, data, research, analytics and solutions. A strong track record of growth, culture of innovation and global footprint sets us apart. We have delivered independent opinions, actionable insights, and efficient solutions to over 1,00,000 customers.
 
We are majority owned by S&P Global Inc., a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide.
 
For more information, visit www.crisil.com 


Connect with us: TWITTER | LINKEDIN | YOUTUBE | FACEBOOK

About CRISIL Ratings
CRISIL Ratings is part of CRISIL Limited (“CRISIL”). We pioneered the concept of credit rating in India in 1987. CRISIL is registered in India as a credit rating agency with the Securities and Exchange Board of India (“SEBI”). With a tradition of independence, analytical rigour and innovation, CRISIL sets the standards in the credit rating business. We rate the entire range of debt instruments, such as, bank loans, certificates of deposit, commercial paper, non-convertible / convertible / partially convertible bonds and debentures, perpetual bonds, bank hybrid capital instruments, asset-backed and mortgage-backed securities, partial guarantees and other structured debt instruments. We have rated over 24,500 large and mid-scale corporates and financial institutions. CRISIL has also instituted several innovations in India in the rating business, including rating municipal bonds, partially guaranteed instruments and microfinance institutions. We also pioneered a globally unique rating service for Micro, Small and Medium Enterprises (MSMEs) and significantly extended the accessibility to rating services to a wider market. Over 1,10,000 MSMEs have been rated by us.


CRISIL PRIVACY
 
CRISIL respects your privacy. We may use your contact information, such as your name, address, and email id to fulfil your request and service your account and to provide you with additional information from CRISIL.For further information on CRISIL’s privacy policy please visit www.crisil.com.


DISCLAIMER

This disclaimer forms part of and applies to each credit rating report and/or credit rating rationale that we provide (each a “Report”). For the avoidance of doubt, the term “Report” includes the information, ratings and other content forming part of the Report. The Report is intended for the jurisdiction of India only. This Report does not constitute an offer of services. Without limiting the generality of the foregoing, nothing in the Report is to be construed as CRISIL providing or intending to provide any services in jurisdictions where CRISIL does not have the necessary licenses and/or registration to carry out its business activities referred to above. Access or use of this Report does not create a client relationship between CRISIL and the user.

We are not aware that any user intends to rely on the Report or of the manner in which a user intends to use the Report. In preparing our Report we have not taken into consideration the objectives or particular needs of any particular user. It is made abundantly clear that the Report is not intended to and does not constitute an investment advice. The Report is not an offer to sell or an offer to purchase or subscribe for any investment in any securities, instruments, facilities or solicitation of any kind or otherwise enter into any deal or transaction with the entity to which the Report pertains. The Report should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in the US).

Ratings from CRISIL Rating are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold, or sell any securities / instruments or to make any investment decisions. Any opinions expressed here are in good faith, are subject to change without notice, and are only current as of the stated date of their issue. CRISIL assumes no obligation to update its opinions following publication in any form or format although CRISIL may disseminate its opinions and analysis. CRISIL rating contained in the Report is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment or other business decisions. The recipients of the Report should rely on their own judgment and take their own professional advice before acting on the Report in any way.CRISIL or its associates may have other commercial transactions with the company/entity.

Neither CRISIL nor its affiliates, third party providers, as well as their directors, officers, shareholders, employees or agents (collectively, “CRISIL Parties”) guarantee the accuracy, completeness or adequacy of the Report, and no CRISIL Party shall have any liability for any errors, omissions, or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the Report. EACH CRISIL PARTY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall any CRISIL Party be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the Report even if advised of the possibility of such damages.

CRISIL Ratings may receive compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors. CRISIL’s public ratings and analysis as are required to be disclosed under the regulations of the Securities and Exchange Board of India (and other applicable regulations, if any) are made available on its web sites, www.crisil.com (free of charge). Reports with more detail and additional information may be available for subscription at a fee – more details about CRISIL ratings are available here: www.crisilratings.com.

CRISIL and its affiliates do not act as a fiduciary. While CRISIL has obtained information from sources it believes to be reliable, CRISIL does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives and / or relies in its Reports. CRISIL keeps certain activities of its business units separate from each other in order to preserve the independence and objectivity of the respective activity. As a result, certain business units of CRISIL may have information that is not available to other CRISIL business units. CRISIL has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process. CRISIL has in place a ratings code of conduct and policies for analytical firewalls and for managing conflict of interest. For details please refer to: https://www.crisil.com/en/home/our-businesses/ratings/regulatory-disclosures/highlighted-policies.html

CRISIL’s rating criteria are generally available without charge to the public on the CRISIL public web site, www.crisil.com. For latest rating information on any instrument of any company rated by CRISIL you may contact CRISIL RATING DESK at CRISILratingdesk@crisil.com, or at (0091) 1800 267 1301.

This Report should not be reproduced or redistributed to any other person or in any form without a prior written consent of CRISIL.

All rights reserved @ CRISIL